Literature DB >> 20399176

Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain.

Andreas Hinz1, Nolwenn Miguet1, Ganesh Natrajan1, Yoshiko Usami2, Hikaru Yamanaka2, Patricia Renesto1, Bettina Hartlieb1, Andrew A McCarthy3, Jean-Pierre Simorre4, Heinrich Göttlinger2, Winfried Weissenhorn5.   

Abstract

The restriction factor BST-2/tetherin contains two membrane anchors employed to retain some enveloped viruses, including HIV-1 tethered to the plasma membrane in the absence of virus-encoded antagonists. The 2.77 A crystal structure of the BST-2/tetherin extracellular core presented here reveals a parallel 90 A long disulfide-linked coiled-coil domain, while the complete extracellular domain forms an extended 170 A long rod-like structure based on small-angle X-ray scattering data. Mutagenesis analyses indicate that both the coiled coil and the N-terminal region are required for retention of HIV-1, suggesting that the elongated structure can function as a molecular ruler to bridge long distances. The structure reveals substantial irregularities and instabilities throughout the coiled coil, which contribute to its low stability in the absence of disulfide bonds. We propose that the irregular coiled coil provides conformational flexibility, ensuring that BST-2/tetherin anchoring both in the plasma membrane and in the newly formed virus membrane is maintained during virus budding. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399176      PMCID: PMC2859121          DOI: 10.1016/j.chom.2010.03.005

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  54 in total

1.  Situs: A package for docking crystal structures into low-resolution maps from electron microscopy.

Authors:  W Wriggers; R A Milligan; J A McCammon
Journal:  J Struct Biol       Date:  1999 Apr-May       Impact factor: 2.867

2.  Substructure solution with SHELXD.

Authors:  Thomas R Schneider; George M Sheldrick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-09-28

3.  An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein.

Authors:  Stuart J D Neil; Virginie Sandrin; Wesley I Sundquist; Paul D Bieniasz
Journal:  Cell Host Microbe       Date:  2007-09-13       Impact factor: 21.023

4.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

5.  Automated MAD and MIR structure solution.

Authors:  T C Terwilliger; J Berendzen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-04

Review 6.  Human cellular restriction factors that target HIV-1 replication.

Authors:  Klaus Strebel; Jeremy Luban; Kuan-Teh Jeang
Journal:  BMC Med       Date:  2009-09-16       Impact factor: 8.775

7.  HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor.

Authors:  Christine Goffinet; Ina Allespach; Stefanie Homann; Hanna-Mari Tervo; Anja Habermann; Daniel Rupp; Lena Oberbremer; Christian Kern; Nadine Tibroni; Sonja Welsch; Jacomine Krijnse-Locker; George Banting; Hans-Georg Kräusslich; Oliver T Fackler; Oliver T Keppler
Journal:  Cell Host Microbe       Date:  2009-03-19       Impact factor: 21.023

8.  HM1.24 is internalized from lipid rafts by clathrin-mediated endocytosis through interaction with alpha-adaptin.

Authors:  Naoko Masuyama; Toshio Kuronita; Rika Tanaka; Tomonori Muto; Yuko Hirota; Azusa Takigawa; Hideaki Fujita; Yoshinori Aso; Jun Amano; Yoshitaka Tanaka
Journal:  J Biol Chem       Date:  2009-04-08       Impact factor: 5.157

9.  A novel membrane antigen selectively expressed on terminally differentiated human B cells.

Authors:  T Goto; S J Kennel; M Abe; M Takishita; M Kosaka; A Solomon; S Saito
Journal:  Blood       Date:  1994-09-15       Impact factor: 22.113

10.  Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.

Authors:  Daniel Sauter; Michael Schindler; Anke Specht; Wilmina N Landford; Jan Münch; Kyeong-Ae Kim; Jörg Votteler; Ulrich Schubert; Frederic Bibollet-Ruche; Brandon F Keele; Jun Takehisa; Yudelca Ogando; Christina Ochsenbauer; John C Kappes; Ahidjo Ayouba; Martine Peeters; Gerald H Learn; George Shaw; Paul M Sharp; Paul Bieniasz; Beatrice H Hahn; Theodora Hatziioannou; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2009-11-19       Impact factor: 21.023

View more
  96 in total

1.  Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.

Authors:  Raphaël Vigan; Stuart J D Neil
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  C-terminal hydrophobic region in human bone marrow stromal cell antigen 2 (BST-2)/tetherin protein functions as second transmembrane motif.

Authors:  Amy J Andrew; Sandra Kao; Klaus Strebel
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

3.  Virology: cleaving the tether.

Authors:  Christiaan van Ooij
Journal:  Nat Rev Microbiol       Date:  2010-06       Impact factor: 60.633

4.  BST-2 diminishes HIV-1 infectivity.

Authors:  Jianyong Zhang; Chen Liang
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

Review 5.  HIV-1 Vpu - an ion channel in search of a job.

Authors:  Klaus Strebel
Journal:  Biochim Biophys Acta       Date:  2013-07-03

Review 6.  HIV suppression by host restriction factors and viral immune evasion.

Authors:  Xiaofei Jia; Qi Zhao; Yong Xiong
Journal:  Curr Opin Struct Biol       Date:  2015-05-16       Impact factor: 6.809

Review 7.  Host factors involved in retroviral budding and release.

Authors:  Juan Martin-Serrano; Stuart J D Neil
Journal:  Nat Rev Microbiol       Date:  2011-06-16       Impact factor: 60.633

8.  Gag induces the coalescence of clustered lipid rafts and tetraspanin-enriched microdomains at HIV-1 assembly sites on the plasma membrane.

Authors:  Ian B Hogue; Jonathan R Grover; Ferri Soheilian; Kunio Nagashima; Akira Ono
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

9.  HIV-1 Vpu antagonizes BST-2 by interfering mainly with the trafficking of newly synthesized BST-2 to the cell surface.

Authors:  Mathieu Dubé; Catherine Paquay; Bibhuti Bhusan Roy; Mariana G Bego; Johanne Mercier; Eric A Cohen
Journal:  Traffic       Date:  2011-10-03       Impact factor: 6.215

10.  Stimulation of NF-κB activity by the HIV restriction factor BST2.

Authors:  Andrey Tokarev; Marissa Suarez; Wilson Kwan; Kathleen Fitzpatrick; Rajendra Singh; John Guatelli
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.